阿司匹林在冠心病患者中的应用回顾性研究
被引量:4
出处
《实用临床医药杂志》
CAS
2010年第8期108-109,共2页
Journal of Clinical Medicine in Practice
基金
南京市医学科技发展项目基金资助(ykk08128)
参考文献5
-
1Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy[J].Chest,2004,126(3Suppl):234S.
-
2Askie LM,Duley L,Henderson-Smart DJ,et al.Antiplatelet agents for prevention of pre-eclampsia:a meta-analysis of individual patient data[J].Lancet,2007,369(9575):1791.
-
3Olshove VF Jr,Preston T,Gomez D,et al.Perfusion techniques toward bloodless pediatric open heart surgery[J].J Extra Corpor Technol,2010,42(2):122.
-
4Ishikawa Y,Ishikawa J,Ishikawa S,et al.Prehypertension and the risk for cardiovascular disease in the Japanese general population:the Jichi Medical School Cohort Study[J].J Hypertens,2010,28(8):1630.
-
5李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
二级参考文献17
-
1Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181.
-
2Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176.
-
3Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275.
-
4Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621.
-
5Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S.
-
6Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391.
-
7Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304.
-
8Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
-
9Yusuf S,Zhao F,Mehta SR,et al.Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.N Engl J Med,2001,345:494-502.
-
10Juul-Moller S,Edvardsson N,Jahnmatz B,et al.Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris.Lancet,1992,340:1421-1425.
共引文献193
-
1付宁红.心血管内分泌学:内分泌医师面临的挑战[J].医学信息(医学与计算机应用),2014(27):585-585.
-
2陈明,王茜婷.经皮冠状动脉介入治疗抗血小板治疗现状和进展[J].中国医学前沿杂志(电子版),2011,3(3):43-49. 被引量:8
-
3赵冬琴.21例不稳定性心绞痛阿司匹林+氯吡格雷治疗疗效观察[J].中国临床实用医学,2007,1(7). 被引量:1
-
4李小鹰.在动脉硬化性心血管病防治中规范应用阿司匹林[J].中华心血管病杂志,2006,34(5):477-480. 被引量:22
-
5韩雅玲,王效增.不稳定型心绞痛和非ST段抬高心肌梗死的介入治疗[J].中国实用内科杂志,2006,26(8):1131-1133. 被引量:10
-
6吴兆苏.多重心血管病危险综合防治建议[J].中华心血管病杂志,2006,34(12):1061-1071. 被引量:120
-
7李宇华,李学军.剂量与药物治疗及药物发现的关系[J].医药导报,2007,26(1):1-5. 被引量:2
-
8孙卫东.阿司匹林在心血管病防治中的合理应用[J].中国社区医师,2007,23(2):15-16. 被引量:1
-
9崔忠太,邵秀芹,孙庆华,黄浩.某学院校医院门诊处方中不合理用药问题分析[J].中国校医,2007,21(1):42-43. 被引量:1
-
10阮淑萍.阿司匹林抵抗[J].浙江实用医学,2007,12(1):74-75.
同被引文献43
-
1杨靖,何劲松,杨小英.关于阿司匹林在心内科门诊使用情况的调查[J].中国医药导刊,2005,7(2):116-118. 被引量:13
-
2周莉芸,沈冲,姚才良,顾东风,汪宁.253例苏北农民血压与盐摄入干预试验[J].中国公共卫生,2005,21(5):612-613. 被引量:7
-
3乔玉成.运动干预代谢综合征机制研究进展[J].体育科学,2005,25(11):66-71. 被引量:25
-
4吴永慧,庞大庆,张友胜.河北省394名高校青年教师运动知识与行为[J].中国学校卫生,2005,26(11):941-941. 被引量:1
-
5阿司匹林、他汀类药物或二者合用预防男性冠心病的成本效益分析[J].临床荟萃,2006,21(11):774-774. 被引量:1
-
6贾冬梅.原发性高血压伴胰岛素抵抗的综合治疗[J].医药导报,2007,26(5):523-524. 被引量:4
-
7王晓岩,杜凤和.冠心病患者服用阿司匹林前后血小板功能及代谢产物的变化[J].山东医药,2007,47(19):16-18. 被引量:3
-
8Bonora E, Kiechl S, Willelt J, et al. Carotid atherosclerosis and coronary disease in the. metabolic, syndrome prospective data from the bruneck study[J]. Diabetes care,2003,26(4): 1251.
-
9Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovas- cular disease, and all causes in United States adults[J]. Circu- lation, 2004,110(10) : 1245-1250.
-
10Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic sundrome with history of myocardial infarction and stroke in the third National Health and Nutrition Examination survey[J]. Circulation, 2003,119 : 1442-1446.
二级引证文献10
-
1姚淑艳,李玉敏,齐振生.冠心病患者血小板聚集功能与炎症因子水平的临床研究[J].世界最新医学信息文摘,2020(28):59-59.
-
2王娜.阿司匹林在冠心病防治中的临床应用[J].医学信息,2017,30(1):127-128.
-
3万建华,郭琼,金燕.阿司匹林对老年冠心病患者血小板聚集功能的影响[J].当代医学,2014,20(5):100-101. 被引量:4
-
4李京芳,齐书英,杨秀赏.非血运重建急性冠状动脉综合征患者抗血小板治疗依从性影响因素分析[J].临床误诊误治,2015,28(6):89-92. 被引量:2
-
5唐丽敏,路明,高屹.复方丹参滴丸联合阿司匹林对冠心病患者血脂和血小板聚集功能的影响[J].山西医药杂志,2016,45(2):202-204. 被引量:20
-
6阮泽伟,丁祥云.提高冠心病患者二级预防用药管理实践[J].中医药管理杂志,2017,25(3):79-81. 被引量:2
-
7梁永裕.基层医院预防心脑血管疾病服用阿司匹林依从性的影响因素及干预对策[J].海峡药学,2017,29(9):116-118. 被引量:1
-
8潘小波.心脑血管疾病患者阿司匹林治疗依从性相关影响因素分析[J].临床合理用药杂志,2018,11(19):9-11. 被引量:2
-
9吕锡杰,许梅华.基于阿司匹林用药依从性的干预研究[J].世界最新医学信息文摘,2016,16(58). 被引量:1
-
10吴晓东.老年冠心病患者采用不同剂量阿司匹林抗血小板治疗对其血小板聚集率的影响[J].世界最新医学信息文摘,2016,16(89):57-58. 被引量:1
-
1戴小华.不稳定性冠状动脉病变临床治疗新进展[J].中国中西医结合急救杂志,1999,6(8):380-382. 被引量:3
-
2冯涛,王拥军.认识血管性认知障碍的新角度:时间窗、亚型和协同效应[J].中国卒中杂志,2010,5(11):879-881. 被引量:9
-
3张金霞,宫临征,郭彤,孟庆义.主动脉夹层动脉瘤52例临床分析[J].现代医药卫生,2004,20(20):2099-2100. 被引量:1
-
4迟家敏.浅谈代谢综合征[J].糖尿病天地,2007(11):28-28.
-
5胡东霞,田凡清,胡菁.冠心病患者血脂代谢与[凝血]因子Ⅰ的临床分析[J].中国现代医学杂志,2007,17(15):1910-1912.
-
6顾惠君.浅谈冠心病预防、保健、康复[J].健康促进,2002(3):26-28.
-
7郝建军,冯晓鸿,袁付平.Hcy、hs-CRP、LP(a)和DD联合检测对冠心病诊断的意义[J].实验与检验医学,2015,33(4):469-471. 被引量:13
-
8郭涛,张瑞云.冠心病预防的进展[J].医学信息(云南),1996(4):1-3.
-
9娄轶群.冠心病的预防[J].中国社区医师(医学专业),2012,14(13):407-407. 被引量:1
-
10姜家利,王国磊,徐力.同型半胱氨酸和唾液酸联合检测在冠心病预防和诊疗中的应用价值[J].中国实用医刊,2014,41(1):77-78.